THQETF / Fundabrdn Healthcare Opportunities Fund
Verdicts genuinely change. Free email alert the moment THQ's does — no target price to set, unlike a price alert.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
abrdn Healthcare Opportunities Fund
110 holdings · as of 2026-06-30 (4.6 months ago) The fund may have traded since. SEC Form N-PORT is filed quarterly and lags the period it covers, so these are the most recent holdings on file, not the fund’s holdings today.
This fund holds short positions, so exposure is counted gross — long and short both count as exposure rather than netting off, and the weights below therefore sum to 127% of net assets rather than 100%. Shares of the portfolio are shown as shares of that gross exposure.
NON-COMPLIANT 46.34% of portfolio weight is in non-compliant holdings, over the 5% threshold.
110 holdings, 72 matched (75% of weight). Portfolio as of 2026-06-30, filed 2026-08-28. Source: SEC Form N-PORT.
1.02% of this portfolio’s income is non-permissible — weighted across holdings, computed over 68% of portfolio weight (54 of 110 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
38.6% compliant 0.0% questionable 36.4% non-compliant 25.0% unscreened
All holdings (110)
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| UNH UnitedHealth Group Inc | NON_COMPLIANT | 6.07% | AAOIFI20.4% Usmani23.7% Dow Jones Islamic20.4% S&P Shariah18.8% MSCI Islamic23.7% MSCI Islamic M-Series18.8% FTSE Shariah23.7% |
| VeraDermics Inc | UNSCREENED | 5.27% | no in-house ratios for this holding |
| ABT Abbott Laboratories | COMPLIANT | 4.77% | AAOIFI16.6% Usmani28.8% Dow Jones Islamic15.7% S&P Shariah16.2% MSCI Islamic28.8% MSCI Islamic M-Series16.2% FTSE Shariah28.8% |
| MRK Merck & Co Inc | COMPLIANT | 4.41% | AAOIFI15.2% Usmani40.5% Dow Jones Islamic21.0% S&P Shariah20.4% MSCI Islamic40.5% MSCI Islamic M-Series20.4% FTSE Shariah40.5% |
| MDT Medtronic PLC | COMPLIANT | 4.26% | AAOIFI24.4% Usmani31.5% Dow Jones Islamic26.4% S&P Shariah27.4% MSCI Islamic31.4% MSCI Islamic M-Series27.4% FTSE Shariah30.2% |
| TMO Thermo Fisher Scientific Inc | COMPLIANT | 4.19% | AAOIFI20.5% Usmani40.3% Dow Jones Islamic23.4% S&P Shariah22.9% MSCI Islamic40.3% MSCI Islamic M-Series22.9% FTSE Shariah40.3% |
| VERADERMICS, INC. | UNSCREENED | 4.07% | no in-house ratios for this holding |
| ISRG Intuitive Surgical Inc | COMPLIANT | 3.39% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| CVS CVS Health Corp | NON_COMPLIANT | 3.30% | AAOIFI66.4% Usmani29.2% Dow Jones Islamic80.4% S&P Shariah85.9% MSCI Islamic29.2% MSCI Islamic M-Series85.9% FTSE Shariah23.5% |
| DHR Danaher Corp | COMPLIANT | 3.22% | AAOIFI16.4% Usmani28.4% Dow Jones Islamic18.0% S&P Shariah16.8% MSCI Islamic28.4% MSCI Islamic M-Series16.8% FTSE Shariah28.4% |
| Oruka Therapeutics Inc | UNSCREENED | 2.89% | no in-house ratios for this holding |
| uniQure NV | UNSCREENED | 2.77% | no in-house ratios for this holding |
| HUM Humana Inc | NON_COMPLIANT | 2.75% | AAOIFI23.6% Usmani21.8% Dow Jones Islamic36.9% S&P Shariah34.0% MSCI Islamic21.8% MSCI Islamic M-Series34.0% FTSE Shariah21.8% |
| ELV Elevance Health Inc | NON_COMPLIANT | 2.56% | AAOIFI31.9% Usmani24.1% Dow Jones Islamic38.0% S&P Shariah33.6% MSCI Islamic24.1% MSCI Islamic M-Series33.6% FTSE Shariah24.1% |
| BCRX BioCryst Pharmaceuticals Inc | NON_COMPLIANT | 2.53% | AAOIFI21.1% Usmani68.8% Dow Jones Islamic21.3% S&P Shariah23.8% MSCI Islamic68.5% MSCI Islamic M-Series23.8% FTSE Shariah66.9% |
| ABBV AbbVie Inc | COMPLIANT | 2.47% | AAOIFI13.9% Usmani48.9% Dow Jones Islamic19.4% S&P Shariah21.1% MSCI Islamic48.9% MSCI Islamic M-Series21.1% FTSE Shariah48.9% |
| BSX Boston Scientific Corp | COMPLIANT | 2.40% | AAOIFI18.6% Usmani26.3% Dow Jones Islamic10.0% S&P Shariah10.4% MSCI Islamic26.3% MSCI Islamic M-Series10.4% FTSE Shariah26.3% |
| SRPT Sarepta Therapeutics Inc | NON_COMPLIANT | 2.01% | AAOIFI43.1% Usmani32.8% Dow Jones Islamic21.4% S&P Shariah14.9% MSCI Islamic32.8% MSCI Islamic M-Series14.9% FTSE Shariah26.6% |
| NEO NeoGenomics Inc | COMPLIANT | 1.89% | AAOIFI22.5% Usmani32.6% Dow Jones Islamic29.8% S&P Shariah26.9% MSCI Islamic32.2% MSCI Islamic M-Series26.9% FTSE Shariah27.2% |
| PODD Insulet Corp | COMPLIANT | 1.88% | AAOIFI9.5% Usmani28.2% Dow Jones Islamic5.6% S&P Shariah6.0% MSCI Islamic28.2% MSCI Islamic M-Series6.0% FTSE Shariah28.2% |
| State Street Global Advisors | UNSCREENED | 1.86% | no in-house ratios for this holding |
| Praxis Precision Medicines Inc | UNSCREENED | 1.77% | no in-house ratios for this holding |
| SPRY ARS Pharmaceuticals Inc | NON_COMPLIANT | 1.75% | AAOIFI23.3% Usmani38.7% Dow Jones Islamic9.1% S&P Shariah9.8% MSCI Islamic38.7% MSCI Islamic M-Series9.8% FTSE Shariah38.7% |
| Abivax SA | UNSCREENED | 1.68% | no in-house ratios for this holding |
| ALHC Alignment Healthcare Inc | NON_COMPLIANT | 1.66% | AAOIFI21.1% Usmani25.0% Dow Jones Islamic10.2% S&P Shariah12.3% MSCI Islamic25.0% MSCI Islamic M-Series12.3% FTSE Shariah25.0% |
| OHI Omega Healthcare Investors Inc | COMPLIANT | 1.61% | AAOIFI28.2% Usmani39.7% Dow Jones Islamic34.3% S&P Shariah39.3% MSCI Islamic39.7% MSCI Islamic M-Series39.3% FTSE Shariah39.7% |
| WELL Welltower Inc | COMPLIANT | 1.59% | AAOIFI10.6% Usmani26.7% Dow Jones Islamic15.6% S&P Shariah19.1% MSCI Islamic26.7% MSCI Islamic M-Series19.1% FTSE Shariah26.7% |
| VCEL Vericel Corp | COMPLIANT | 1.59% | AAOIFI4.0% Usmani18.5% Dow Jones Islamic4.4% S&P Shariah4.4% MSCI Islamic18.4% MSCI Islamic M-Series4.4% FTSE Shariah0.0% |
| BMY Bristol-Myers Squibb Co | NON_COMPLIANT | 1.55% | AAOIFI37.3% Usmani51.1% Dow Jones Islamic42.2% S&P Shariah44.8% MSCI Islamic51.1% MSCI Islamic M-Series44.8% FTSE Shariah48.9% |
| MOH Molina Healthcare Inc | NON_COMPLIANT | 1.45% | AAOIFI32.7% Usmani25.2% Dow Jones Islamic31.9% S&P Shariah25.7% MSCI Islamic24.1% MSCI Islamic M-Series25.7% FTSE Shariah24.1% |
| WGS GeneDx Holdings Corp | COMPLIANT | 1.43% | AAOIFI7.1% Usmani27.8% Dow Jones Islamic5.7% S&P Shariah7.7% MSCI Islamic27.8% MSCI Islamic M-Series7.7% FTSE Shariah27.8% |
| ACHC Acadia Healthcare Co Inc | NON_COMPLIANT | 1.26% | AAOIFI71.3% Usmani45.1% Dow Jones Islamic101.6% S&P Shariah64.8% MSCI Islamic45.1% MSCI Islamic M-Series64.8% FTSE Shariah42.3% |
| DOC Healthpeak Properties Inc | NON_COMPLIANT | 1.26% | AAOIFI66.9% Usmani41.9% Dow Jones Islamic76.6% S&P Shariah79.8% MSCI Islamic41.9% MSCI Islamic M-Series79.8% FTSE Shariah41.9% |
| ABT ABBOTT LABORATORIES (the issuer's debt, not its shares) | UNSCREENED | 1.24% | no in-house ratios for this holding |
| CRL Charles River Laboratories International Inc | COMPLIANT | 1.22% | AAOIFI17.7% Usmani38.3% Dow Jones Islamic30.3% S&P Shariah28.5% MSCI Islamic38.3% MSCI Islamic M-Series28.5% FTSE Shariah32.8% |
| VTR Ventas Inc | COMPLIANT | 1.19% | AAOIFI28.0% Usmani42.8% Dow Jones Islamic38.5% S&P Shariah45.5% MSCI Islamic42.8% MSCI Islamic M-Series45.5% FTSE Shariah42.8% |
| OCSAW Oculis Holding AG | NON_COMPLIANT | 1.16% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.0% MSCI Islamic M-Series— FTSE Shariah0.0% |
| ZTS Zoetis Inc | NON_COMPLIANT | 1.14% | AAOIFI29.0% Usmani61.3% Dow Jones Islamic15.4% S&P Shariah14.0% MSCI Islamic61.3% MSCI Islamic M-Series14.0% FTSE Shariah60.0% |
| SBRA Sabra Health Care REIT Inc | NON_COMPLIANT | 1.14% | AAOIFI49.4% Usmani47.6% Dow Jones Islamic61.2% S&P Shariah69.2% MSCI Islamic47.6% MSCI Islamic M-Series69.2% FTSE Shariah47.6% |
| BDSX Biodesix Inc | NON_COMPLIANT | 1.08% | AAOIFI73.7% Usmani80.1% Dow Jones Islamic57.4% S&P Shariah50.8% MSCI Islamic80.1% MSCI Islamic M-Series50.8% FTSE Shariah53.2% |
| SYK Stryker Corp | COMPLIANT | 1.05% | AAOIFI14.6% Usmani32.2% Dow Jones Islamic11.3% S&P Shariah11.8% MSCI Islamic32.2% MSCI Islamic M-Series11.8% FTSE Shariah31.2% |
| CI CIGNA GROUP/THE (the issuer's debt, not its shares) | NON_COMPLIANT | 1.05% | no in-house ratios for this holding |
| ICLR ICON PLC | COMPLIANT | 1.05% | AAOIFI22.8% Usmani21.6% Dow Jones Islamic26.9% S&P Shariah20.7% MSCI Islamic21.6% MSCI Islamic M-Series20.7% FTSE Shariah20.8% |
| JNJ JOHNSON & JOHNSON (the issuer's debt, not its shares) | UNSCREENED | 0.98% | no in-house ratios for this holding |
| PFE PFIZER INC (the issuer's debt, not its shares) | NON_COMPLIANT | 0.96% | no in-house ratios for this holding |
| GEHC GE HealthCare Technologies Inc | NON_COMPLIANT | 0.94% | AAOIFI27.6% Usmani27.1% Dow Jones Islamic30.5% S&P Shariah29.5% MSCI Islamic27.0% MSCI Islamic M-Series29.5% FTSE Shariah26.0% |
| WAT Waters Corp | COMPLIANT | 0.93% | AAOIFI10.7% Usmani20.1% Dow Jones Islamic18.0% S&P Shariah19.9% MSCI Islamic20.1% MSCI Islamic M-Series19.9% FTSE Shariah18.6% |
| MCK McKesson Corp | COMPLIANT | 0.91% | AAOIFI9.5% Usmani12.9% Dow Jones Islamic12.6% S&P Shariah14.0% MSCI Islamic12.9% MSCI Islamic M-Series14.0% FTSE Shariah10.8% |
| MYGN Myriad Genetics Inc | NON_COMPLIANT | 0.91% | AAOIFI39.4% Usmani34.4% Dow Jones Islamic32.8% S&P Shariah19.1% MSCI Islamic34.4% MSCI Islamic M-Series19.1% FTSE Shariah19.9% |
| Disc Medicine Inc | UNSCREENED | 0.89% | no in-house ratios for this holding |
| IQV IQVIA Holdings Inc | NON_COMPLIANT | 0.86% | AAOIFI37.4% Usmani53.5% Dow Jones Islamic48.0% S&P Shariah44.6% MSCI Islamic53.5% MSCI Islamic M-Series44.6% FTSE Shariah52.7% |
| RGEN Repligen Corp | COMPLIANT | 0.80% | AAOIFI7.3% Usmani23.4% Dow Jones Islamic8.8% S&P Shariah8.4% MSCI Islamic23.4% MSCI Islamic M-Series8.4% FTSE Shariah18.7% |
| TMO THERMO FISHER SCIENTIFIC (the issuer's debt, not its shares) | UNSCREENED | 0.78% | no in-house ratios for this holding |
| RCUS Arcus Biosciences Inc | COMPLIANT | 0.78% | AAOIFI4.0% Usmani12.3% Dow Jones Islamic5.6% S&P Shariah6.2% MSCI Islamic12.3% MSCI Islamic M-Series6.2% FTSE Shariah10.9% |
| INSP Inspire Medical Systems Inc | COMPLIANT | 0.76% | AAOIFI1.7% Usmani3.0% Dow Jones Islamic0.9% S&P Shariah0.7% MSCI Islamic3.0% MSCI Islamic M-Series0.7% FTSE Shariah0.0% |
| BDX Becton Dickinson & Co | NON_COMPLIANT | 0.73% | AAOIFI33.4% Usmani33.1% Dow Jones Islamic30.8% S&P Shariah28.7% MSCI Islamic33.1% MSCI Islamic M-Series28.7% FTSE Shariah33.1% |
| Mineralys Therapeutics Inc | UNSCREENED | 0.72% | no in-house ratios for this holding |
| THIRD ARC BIO, INC | UNSCREENED | 0.69% | no in-house ratios for this holding |
| UNH UNITEDHEALTH GROUP INC (the issuer's debt, not its shares) | NON_COMPLIANT | 0.69% | no in-house ratios for this holding |
| ZBH ZIMMER BIOMET HOLDINGS (the issuer's debt, not its shares) | NON_COMPLIANT | 0.67% | no in-house ratios for this holding |
| LTC LTC Properties Inc | NON_COMPLIANT | 0.65% | AAOIFI41.7% Usmani35.8% Dow Jones Islamic57.5% S&P Shariah63.1% MSCI Islamic35.8% MSCI Islamic M-Series63.1% FTSE Shariah35.8% |
| AZN ASTRAZENECA PLC (the issuer's debt, not its shares) | UNSCREENED | 0.64% | no in-house ratios for this holding |
| ELV ELEVANCE HEALTH INC (the issuer's debt, not its shares) | NON_COMPLIANT | 0.64% | no in-house ratios for this holding |
| CI CIGNA GROUP/THE (the issuer's debt, not its shares) | NON_COMPLIANT | 0.63% | no in-house ratios for this holding |
| UNH UNITEDHEALTH GROUP INC (the issuer's debt, not its shares) | NON_COMPLIANT | 0.58% | no in-house ratios for this holding |
| GLYCOMINE, INC. | UNSCREENED | 0.54% | no in-house ratios for this holding |
| CRYSTALYS THERAPEUTICS SER A | UNSCREENED | 0.51% | no in-house ratios for this holding |
| LUCD Lucid Diagnostics Inc | NON_COMPLIANT | 0.50% | AAOIFI22.4% Usmani66.4% Dow Jones Islamic13.2% S&P Shariah16.8% MSCI Islamic66.4% MSCI Islamic M-Series16.8% FTSE Shariah62.1% |
| MRK MERCK & CO INC (the issuer's debt, not its shares) | UNSCREENED | 0.47% | no in-house ratios for this holding |
| Perceptive Capital Solutions Corp | UNSCREENED | 0.47% | no in-house ratios for this holding |
| CDNA CareDx Inc | COMPLIANT | 0.44% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| ENDEAVOR BIOMEDICINES, INC. | UNSCREENED | 0.42% | no in-house ratios for this holding |
| SYK STRYKER CORP (the issuer's debt, not its shares) | UNSCREENED | 0.42% | no in-house ratios for this holding |
| SEISMIC THERAPEUTICS, INC. | UNSCREENED | 0.40% | no in-house ratios for this holding |
| CVS CVS HEALTH CORP (the issuer's debt, not its shares) | NON_COMPLIANT | 0.40% | no in-house ratios for this holding |
| ELV ELEVANCE HEALTH INC (the issuer's debt, not its shares) | NON_COMPLIANT | 0.36% | no in-house ratios for this holding |
| PFE PFIZER INC (the issuer's debt, not its shares) | NON_COMPLIANT | 0.36% | no in-house ratios for this holding |
| TNDM Tandem Diabetes Care Inc | NON_COMPLIANT | 0.35% | AAOIFI53.4% Usmani64.0% Dow Jones Islamic49.0% S&P Shariah43.9% MSCI Islamic64.0% MSCI Islamic M-Series43.9% FTSE Shariah52.2% |
| SpyGlass Pharma Inc | UNSCREENED | 0.35% | no in-house ratios for this holding |
| DXCM Dexcom Inc | COMPLIANT | 0.35% | AAOIFI4.4% Usmani22.3% Dow Jones Islamic4.6% S&P Shariah4.0% MSCI Islamic21.5% MSCI Islamic M-Series4.0% FTSE Shariah19.9% |
| ALKS Alkermes PLC | COMPLIANT | 0.34% | AAOIFI19.9% Usmani35.4% Dow Jones Islamic27.5% S&P Shariah29.8% MSCI Islamic35.4% MSCI Islamic M-Series29.8% FTSE Shariah33.8% |
| DHC Diversified Healthcare Trust | NON_COMPLIANT | 0.33% | AAOIFI134.3% Usmani57.6% Dow Jones Islamic211.6% S&P Shariah249.7% MSCI Islamic57.6% MSCI Islamic M-Series249.7% FTSE Shariah57.6% |
| MOBI Mobia Medical Inc | NON_COMPLIANT | 0.32% | AAOIFI0.3% Usmani0.6% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.6% MSCI Islamic M-Series— FTSE Shariah0.0% |
| ABBV ABBVIE INC (the issuer's debt, not its shares) | UNSCREENED | 0.32% | no in-house ratios for this holding |
| LLY Eli Lilly & Co | COMPLIANT | 0.32% | AAOIFI3.7% Usmani33.4% Dow Jones Islamic5.6% S&P Shariah5.9% MSCI Islamic33.4% MSCI Islamic M-Series5.9% FTSE Shariah33.4% |
| SERA Sera Prognostics Inc | NON_COMPLIANT | 0.30% | AAOIFI3.7% Usmani3.5% Dow Jones Islamic2.8% S&P Shariah2.3% MSCI Islamic3.5% MSCI Islamic M-Series2.3% FTSE Shariah0.0% |
| ELV ELEVANCE HEALTH INC (the issuer's debt, not its shares) | NON_COMPLIANT | 0.24% | no in-house ratios for this holding |
| THC Tenet Healthcare Corp | NON_COMPLIANT | 0.24% | AAOIFI63.5% Usmani43.2% Dow Jones Islamic83.2% S&P Shariah95.3% MSCI Islamic43.2% MSCI Islamic M-Series95.3% FTSE Shariah43.2% |
| CVS CVS HEALTH CORP (the issuer's debt, not its shares) | NON_COMPLIANT | 0.24% | no in-house ratios for this holding |
| Seaport Therapeutics Inc | UNSCREENED | 0.23% | no in-house ratios for this holding |
| ATALANTA THERAPEUTICS | UNSCREENED | 0.23% | no in-house ratios for this holding |
| ATALANTA THERAPEUTICS | UNSCREENED | 0.21% | no in-house ratios for this holding |
| Revolution Medicines Inc | UNSCREENED | 0.20% | no in-house ratios for this holding |
| HR Healthcare Realty Trust Inc | NON_COMPLIANT | 0.19% | AAOIFI65.0% Usmani47.4% Dow Jones Islamic73.0% S&P Shariah75.9% MSCI Islamic47.4% MSCI Islamic M-Series75.9% FTSE Shariah47.4% |
| CI CIGNA GROUP/THE (the issuer's debt, not its shares) | NON_COMPLIANT | 0.18% | no in-house ratios for this holding |
| DH EUROPE FINANCE II | UNSCREENED | 0.17% | no in-house ratios for this holding |
| ABCURO, INC. | UNSCREENED | 0.15% | no in-house ratios for this holding |
| ODTX Odyssey Therapeutics Inc | NON_COMPLIANT | 0.11% | AAOIFI2.5% Usmani5.4% Dow Jones Islamic— S&P Shariah— MSCI Islamic5.4% MSCI Islamic M-Series— FTSE Shariah0.0% |
| KLRA Kailera Therapeutics Inc | NON_COMPLIANT | 0.11% | AAOIFI0.6% Usmani0.9% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.9% MSCI Islamic M-Series— FTSE Shariah0.0% |
| ENDEAVOR BIOMEDICINES INC. | UNSCREENED | 0.11% | no in-house ratios for this holding |
| NSPR InspireMD Inc | NON_COMPLIANT | 0.11% | AAOIFI4.9% Usmani4.4% Dow Jones Islamic2.8% S&P Shariah2.9% MSCI Islamic4.4% MSCI Islamic M-Series2.9% FTSE Shariah0.0% |
| ABCURO INC. | UNSCREENED | 0.10% | no in-house ratios for this holding |
| ENGRAIL THERAPEUTICS INC. SERI | UNSCREENED | 0.10% | no in-house ratios for this holding |
| Avalyn Pharma Inc | UNSCREENED | 0.08% | no in-house ratios for this holding |
| Hemab Therapeutics Holdings Inc | UNSCREENED | 0.07% | no in-house ratios for this holding |
| NHI National Health Investors Inc | NON_COMPLIANT | 0.05% | AAOIFI35.3% Usmani32.1% Dow Jones Islamic30.8% S&P Shariah33.5% MSCI Islamic32.1% MSCI Islamic M-Series33.5% FTSE Shariah32.1% |
| OCULIS HOLDINGS AG | UNSCREENED | 0.04% | no in-house ratios for this holding |
| Options Clearing Corp. | UNSCREENED | 0.02% | no in-house ratios for this holding |
| CONTRA FUSION PHARMACE | UNSCREENED | 0.00% | no in-house ratios for this holding |
| IO LIGHT HOLDINIGS, INC. | UNSCREENED | 0.00% | no in-house ratios for this holding |
The published standards disagree about this fund by 25 points of portfolio weight — 61.8% of it passes Dow Jones Islamic, 36.4% passes MSCI Islamic. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 57.5% ratios fail on 26.7% 43.2% not rated under AAOIFI
ratios pass on 43.2% ratios fail on 41.4% 42.8% not rated under Usmani
ratios pass on 61.8% ratios fail on 22.4% 43.2% not rated under Dow Jones Islamic
ratios pass on 61.8% ratios fail on 22.3% 43.3% not rated under S&P Shariah
ratios pass on 36.4% ratios fail on 49.3% 41.6% not rated under MSCI Islamic
ratios pass on 61.8% ratios fail on 22.4% 43.2% not rated under MSCI Islamic M-Series
ratios pass on 46.2% ratios fail on 39.9% 41.2% not rated under FTSE Shariah
59 of 110 listed holdings carry our own per-methodology verdicts (89% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 58 (88% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| UNH UnitedHealth Group Inc | 6.07% |
| CVS CVS Health Corp | 3.30% |
| HUM Humana Inc | 2.75% |
| ELV Elevance Health Inc | 2.56% |
| BCRX BioCryst Pharmaceuticals Inc | 2.53% |
| SRPT Sarepta Therapeutics Inc | 2.01% |
| SPRY ARS Pharmaceuticals Inc | 1.75% |
| ALHC Alignment Healthcare Inc | 1.66% |
| BMY Bristol-Myers Squibb Co | 1.55% |
| MOH Molina Healthcare Inc | 1.45% |
Methodology breakdown computing — it will appear here on its own.
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Why this signal?
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
abrdn Healthcare Opportunities Fund (THQ) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
🕌 In-house Compliance Research
Computing the full ratio and business-activity breakdown for THQ — this runs off the critical path so the page paints first. It will appear here on its own.
| Investor | Firm | Position | Weight | As of |
|---|---|---|---|---|
| Ken Griffin | Citadel Advisors | $0M | 0.0% | 2026-09-30 |
| Israel Englander | Millennium Management | $0M | 0.0% | 2026-09-30 |
From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 47.60 | NEUTRAL |
| Stochastic %K (14) | 19.34 | BUY |
| CCI (20) | -45.50 | NEUTRAL |
| Williams %R (14) | -80.66 | BUY |
| MACD (12,26,9) | -0.01 | SELL |
| ROC (10) | 1.09 | BUY |
| Momentum (10) | 0.20 | BUY |
| EMA (10) | 18.89 | SELL |
| SMA (10) | 19.01 | SELL |
| EMA (20) | 18.74 | SELL |
| SMA (20) | 18.76 | SELL |
| EMA (30) | 18.64 | SELL |
| SMA (30) | 18.41 | BUY |
| EMA (50) | 18.56 | SELL |
| SMA (50) | 18.41 | BUY |
| EMA (100) | 18.39 | BUY |
| SMA (100) | 18.53 | BUY |
| EMA (200) | 17.92 | BUY |
| SMA (200) | 17.85 | BUY |
About abrdn Healthcare Opportunities Fund
Financial Services · Asset Management
Abrdn Healthcare Opportunities Fund is a closed ended balanced mutual fund launched and managed by abrdn Inc. The fund invests in public equity and fixed income markets across the globe. It seeks to invest in securities of companies operating in the healthcare sector. The fund also invests in pooled investment vehicles. For its fixed income portion, the fund invests in corporate debt securities across the credit rating spectrum. It benchmarks the performance of its portfolio against the S&P 1500 Healthcare Index and S&P 500 Index. Abrdn Healthcare Opportunities Fund was formed on April 2, 2014 and is domiciled in the United States.
Background via Yahoo Finance — informational, not part of the verdict.
Average — needs more confirmation before sizing up
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BULLISH | 42 |
| ⏰ 4H | BULLISH | 29 |
| 🕐 1H | BEARISH | 98 |
| ⏱ 15-Min | BEARISH | 130 |
| ⏲ 5-Min | BEARISH | 234 |
Momentum & Volume
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
Peer Movement
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is a fund screened on its name?
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
What does unrated weight mean?
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
Does the issuer's board make it compliant?
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
How often is this re-screened?
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Insider Activity (90d)
Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.
NO DATA 0 buys · 0 sells
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-11-10 · Asset managers net 914130 (-14454)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.